Balsm Alofoq Medical Company (SASE: 9620)
Health Care · Health Care Providers & Services · SA
SR22.00
-1.43% today · -27.2% 1Y
Balsm Alofoq Medical Company (SASE: 9620) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $14.65M.
Over the last twelve months the share price has lost 27.2%, trading between 22.00 and 32.25.
Tweenvest scores Balsm Alofoq Medical Company across four factors: quality 88/100, value 50/100. Its strongest factor is quality.
9620 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.65M
- Revenue (TTM)
- $5.87M
- P/E
- 38.51
- EPS
- 0.57
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- SR32.25
- 52-week low
- SR22.00
- Avg volume (3M)
- —
- Shares outstanding
- 2.50M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| G3 Global BerhadKLSE: G3 | $15.24M | RM0.02 | +50.00% |
| INOVIQ LtdASX: IIQ | $15.23M | AU$0.16 | -8.82% |
| Avem Health Partners, Inc.OTCPK: FPCG | $15.17M | $— | — |
| Syra Health Corp.OTCPK: SYRA | $14.91M | $0.86 | +4.23% |
| IBL HealthCare LimitedKASE: IBLHL | $14.63M | PKRs41.12 | -1.23% |
| EuKedos S.p.A.BIT: EUK | $14.39M | €0.57 | +10.78% |
| CEDAR.Co.,Ltd.TSE: 2435 | $14.32M | ¥202.00 | -1.46% |
| Nephro Care India LimitedNSEI: NEPHROCARE | $14.30M | Rs83.95 | -6.36% |
Figures last refreshed Oct 11, 2026.